The University of Tennessee Health Science Center received a $250,000 grant from Pfizer Pharmaceuticals to expand the number of medical professionals working in rheumatology, specifically by adding physician assistants and family nurse practitioners. The principal investigator is Dr. Debendra Pattanaik in the college of medicine.
Daily Memphian: News that several dozen Shelby County Schools have tested positive for lead in the drinking water has amped up attention on an issue that local experts say needs a megaphone. “We have over 200,000 homes in our city that are at high risk for lead exposure,” said Dr. Jason Yaun, associate professor in… Read More
The University of Tennessee Health Science Center is knee-deep in negotiations to add West Tennessee Healthcare to its network of teaching hospitals.
Faculty and staff from multiple University of Tennessee campuses gathered in Nashville on Friday to discuss measures that can help improve mental health for both students and faculty. The 2019 Academic and Student Affairs Summit took place in the Nelson Andrews Leadership Lodge and covered methods that the University of Tennessee Health Science Center was… Read More
Data presented at ASN Kidney Week suggested higher dietary protein intake is associated with increased risk for all-cause mortality and ESRD in patients with chronic kidney disease, with researchers also observing a decline in dietary protein intake with progressive loss of kidney function. “Protein energy wasting is common in patients with CKD, but the trajectory… Read More
Survivors of sepsis–a life-threatening response to an infection–have expressed a need for advocacy and follow-up support, according to a study authored by professors at the University of Tennessee, Knoxville, and the University of Tennessee Health Science Center in Memphis, and published in Dimensions of Critical Care Nursing.
Novartis announced today that the US Food and Drug Administration (FDA) approved Adakveo® (crizanlizumab), previously known as SEG101, to reduce the frequency of vaso-occlusive crises (VOCs), or pain crises, in adult and pediatric patients aged 16 years and older with sickle cell disease.4 Adakveo represents the first FDA-approved medicine in sickle cell disease that binds… Read More
In addressing faculty and staff at his annual State of University Address on Nov. 15, Dr. Steve Schwab, chancellor of the University of Tennessee Health Science Center, noted the distance between the UTHSC’s Memphis and Nashville campuses. “Maybe there is room for another campus,” he said.
